These data indicate that CD8+ T cells, as opposed to NK cells or CD4+ T cells, are the critical cellular components contributing to antitumor immunity and play a pivotal role in preventing tumor recurrence induced by the combination of MWA and Flt3L treatment. The gene discussed is CD4; the disease is neoplasm.